MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ: MSLE · HEALTHCARE · BIOTECHNOLOGY
$7.27
-4.47% today
Updated 2026-04-29
Market cap
$149.15M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$5 – $13
Volume
0.1M
Satellos Bioscience Inc. Common Stock (MSLE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | $94052.00 | — | — | — | — |
| Gross profit | $-94052.00 | — | — | — | — |
| Gross margin | — | — | — | — | — |
| R&D | $1.57M | $2.75M | $6.65M | $13.66M | $18.43M |
| SG&A | $1.13M | $2.92M | $4.57M | $5.16M | $7.44M |
| Operating income | $-3.69M | $-6.21M | $-11.66M | $-19.38M | $-26.46M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-11.26M | $-8.09M | $-11.84M | $-19.56M | — |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-11.39M | $-8.34M | $-11.84M | $-19.58M | — |
| Interest expense | $772797.00 | $0.00 | $133423.00 | $0.00 | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-12.16M | $-8.34M | $-11.98M | $-19.58M | $-24.87M |
| Net income growth (YoY) | — | +31.4% | -43.6% | -63.5% | -27.0% |
| Profit margin | — | — | — | — | — |